C. Ronald Kahn, MD, is an internationally recognized expert in diabetes and obesity research, as well as a preeminent investigator in the area of insulin signal transduction and mechanisms of altered ...

Joslin Diabetes Center is the world's largest diabetes research and clinical care organization. Joslin is dedicated to ensuring that people with diabetes live long, healthy lives. Joslin's clinic ...

We offer a comprehensive 60-minute individual session that includes an evaluation of self-care behaviors: problem-solving, managing hyperglycemia, hypoglycemia, and the ability to self-manage blood ...

In the late 19th century, diabetes was considered a very obscure disease, and there was little in the way of treatment. But, both personal and professional experiences led Elliott P. Joslin, MD to ...

Dr. Gordon Weir is a member of the Section on Islet and Regenerative Biology, holds the Diabetes Research and Wellness Foundation Chair at Joslin, and is Professor of Medicine at Harvard Medical ...

Dr. Roeland J.W. Middelbeek is a Staff Physician at the Joslin Diabetes Center. Dr. Middelbeek obtained his medical degree from VU University Medical Center in Amsterdam, the Netherlands. He completed ...

Originally from the Boston area, Jonathan Dreyfuss received his BA from McGill University, his MS from the Department of Statistics and Operations Research at the University of North Carolina – Chapel ...

Dr. Sun is a vitreoretinal surgeon and Chief of the Center for Clinical Eye Research and Trials of the Beetham Eye Institute, Joslin Diabetes Center. She is an Associate Professor of Ophthalmology at ...

At The Beetham Eye Institute, generations of Joslin ophthalmologists have revolutionized the diagnosis and treatment of diabetic eye disease. William P. Beetham, MD, for whom the Institute was named, ...

30.3 million people have diabetes (9.4% of the US population), in one type or another. 84.1 million adults aged 18 years or older have prediabetes (33.9% of the adult US population. But what exactly ...

The Diabetes Remission Outcome Program (DROP) is a 12-week weight management program targeting those who have been diagnosed with diabetes for less than five years, have an A1C less than 8%, and are ...

Dr. Mary-Elizabeth Patti is a physician-scientist, serving as a Principal Investigator at Joslin Diabetes Center, Director of the Hypoglycemia Clinic, Co-Director of the Molecular Phenotyping Core, ...